Pequot Resources Inc (REON) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2012

Resolute Oncology Inc

CIK: 1470022 Ticker: REON

View differences made from one quarter to another to evaluate Resolute Oncology Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Resolute Oncology Inc.


Assess how Resolute Oncology Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Resolute Oncology Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: REON
CIK: 1470022
Form Type: 10-Q Quarterly Report
Accession Number: 0001038838-12-000202
Submitted to the SEC: Mon Aug 13 2012 4:51:51 PM EST
Accepted by the SEC: Mon Aug 13 2012
Period: Saturday, June 30, 2012
Industry: Metal Mining

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: